NCT00504712View on ClinicalTrials.gov

Testosterone for Peripheral Vascular Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HypogonadismPeripheral Vascular DiseaseType 2 Diabetes
Interventions
DRUG

Testosterone

Sustanon- 200mg- Intramuscular testosterone every 2 weeks

DRUG

saline

Saline injection every two weeks

Trial Locations (1)

S75 2EP

Barnsley Hospital NHS Foundation Trust, Barnsley

All Listed Sponsors
lead

Barnsley Hospital

OTHER

NCT00504712 - Testosterone for Peripheral Vascular Disease | Biotech Hunter | Biotech Hunter